Mier Tuo (迷尔脱)迷尔脱
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江西广信药业有限公司Chinese legal name: 江西广信药业有限公司
主要成分Active Ingredients
- 甲硝唑Jiaxiao Zuo
药物知识说明
甲硝唑是一种在国家药监局注册认定的药品。该药品含有甲硝唑-fa123757等成分。
该药品关联的活性成分包括：甲硝唑Jiaxiao Zuo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：江西广信药业有限公司Chinese legal name: 江西广信药业有限公司。
您可以探索含有相同成分的其他药品：甲硝唑-fa123757成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 迷尔脱) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 甲硝唑Jiaxiao Zuo.
Manufacturers recorded for this product: 江西广信药业有限公司Chinese legal name: 江西广信药业有限公司.
Explore other medicines containing the same ingredient: 甲硝唑 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 迷尔脱Recorded Chinese name: 迷尔脱
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 3mg×12片×2板3 mg × 12 tablets × 2 blister boards
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 江西广信药业有限公司Chinese legal name: 江西广信药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10980058
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10980058
Manufacturer
Chinese legal name: 江西广信药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10980058
生产企业
江西广信药业有限公司(国产)
适应症
用于牙龈炎、牙周炎、冠周炎及口腔溃疡。
用法用量
将本品置于牙龈和龈颊沟间含服（用于口腔溃疡时粘附于黏膜患处），一次1片，一日3次。饭后用，临睡前加用1片。
不良反应
偶见口干、黏膜刺激等过敏反应，长期使用可引起味觉改变，停药后可消失。
禁忌
1.孕妇及哺乳期妇女禁用。
2.有活动性中枢神经疾患者禁用。
注意事项
1.使用5日后，症状未见缓解，应咨询医师。
2.用药期间不得饮酒或含酒精的饮料。
3.如服用过量或出现严重不良反应，应立即就医。
4.对本品过敏者禁用，过敏体质者慎用。
5.本品性状发生改变时禁止使用。
6.请将本品放在儿童不能接触的地方。
7.儿童必须在成人监护下使用。
8.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
密封。
规格
3mg×12片×2板
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.